| Common Name | MG-A271, MGA271 |
|---|---|
| Synonyms | B7-H3;CD276;B7 homolog 3 |
| Applications | ELISA; Flow Cyt |
| Recommended Dilutions | Flow Cyt 1:100 |
| Formulation & Reconstitution | Lyophilized from sterile PBS, pH 7.4. Normally 5 % – 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions of reconstitution. |
| Host Species | Humanized |
| IgG type | IgG1 |
| Reactivity | Human |
| Target | |
| Uniprot ID | Q5ZPR3 |
| Description | Anti-B7-H3 (enoblituzumab biosimilar) mAb |
| Delivery | In Stock |
| Storage & Shipping | Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature. |
| Background | Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals. |
| Usage | Research use only |
Anti-B7-H3 (enoblituzumab biosimilar) mAb
Price: 50μg $80.00 ; 100 μg $160.00
Product Data
Images
Figure 1. ELISA plate pre-coated by 2 μg/ml (100 μl/well) Human B7-H3, mFc-His tagged protein (PME100012) can bind Anti-B7-H3 Neutralizing antibody in a linear range of 0.24-31.25 ng/ml.
Figure 2. HEK293 cell line transfected with irrelevant protein (B) and human B7-H3 (A) were surface stained with anti-B7H3 neutralizing antibody 1μg/ml (enoblituzumab) followed by Alexa 488-conjugated anti-human IgG secondary antibody.